Concepedia

Publication | Open Access

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer

DOIFull Paper Access

43

Citations

17

References

2015

Year

Se‐Il Go, Gyung Hyuck Ko, Won Sup Lee, Rock Bum Kim, Jeong-Hee Lee, Sang-Ho Jeong, Young‐Joon Lee, Soon‐Chan Hong, Woo Song Ha
Cancer Research and Treatment

Abstract

This study suggests that CD44v9 may be a good biomarker for prognosis prediction and for chemoprevention or biomarker-driven therapies only for EGC.

References

YearCitations

Page 1